This metabolic inflammatory environment not only promotes diabetes progression by inducing insulin resistance and β-cell dysfunction but also fosters a protumor microenvironment by activating key signaling pathways such as nuclear factor kappa-B (NF-κB) and signal transducer and activator of transcription 3 (STAT3) (72, 74–76). Here, STAT3 is linked to diabetes mellitus.